Abstract

Use of 8.4% Sodium Bicarbonate in Buffering Commonly Administered Vancomycin Hydrochloride Solutions for Use with Midline or Peripheral Line Catheters

Author(s): Puertos Enrique, Spencer Melissa

Issue: Jul/Aug 2015 - Volume 19, Number 4

Page(s): 334-336

Download in electronic PDF format for $75
  • Use of 8.4% Sodium Bicarbonate in Buffering Commonly Administered Vancomycin Hydrochloride Solutions for Use with Midline or Peripheral Line Catheters Page 1
  • Use of 8.4% Sodium Bicarbonate in Buffering Commonly Administered Vancomycin Hydrochloride Solutions for Use with Midline or Peripheral Line Catheters Page 2
  • Use of 8.4% Sodium Bicarbonate in Buffering Commonly Administered Vancomycin Hydrochloride Solutions for Use with Midline or Peripheral Line Catheters Page 3

Abstract

The primary objective of this study was to evaluate the use of 8.4% sodium bicarbonate in the buffering of commonly administered vancomycin hydrochloride solutions for use with midline or peripheral line catheters. Nine admixtures of vancomycin hydrochloride were aseptically prepared for this study. Vancomycin hydrochloride solutions were prepared in triplicates in the following strengths, 1 gram, 2 grams, and 3 grams, which were added to 250-mL bags of sodium chloride 0.9% injection (with overfill). To each prepared solution of vancomycin hydrochloride, 0.5 mL of 8.4% sodium bicarbonate was added. The pH was measured to obtain a baseline level. At day 9, the pH of each sample was measured and compared to those at baseline. The osmolality of each sample was also measured. There was no statistical difference in the pH at baseline and at day 9 (a = 0.05, P = 0.347). A solution of vancomycin hydrochloride that is compounded in 250 mL of sodium chloride 0.9% injection (including overfill) and buffered with 0.5 mL of 8.4% sodium bicarbonate maintained a pH in the range of 5 to 9 and an osmolality in the range of 150 mOsm/kg to 500 mOsm/kg.

Related Keywords

  • vancomycin hydrochloride solutions
  • sodium bicarbonate buffer
  • midline catheter
  • peripheral catheter
  • central line
  • MRSA
  • hospital-based infections
  • staphylococcus
  • streptococcus
  • bacterial infection
  • microbial infection
  • antibacterial
  • antimicrobial
  • pH
  • extravasation
  • compatibility
  • potency

Related Categories

  • EXCIPIENTS
  • INFUSION
  • PARENTERALS
  • PEER-REVIEWED
  • ADVERSE DRUG EVENTS

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jul/Aug 2015
Pg. 334-336
Use of 8.4% Sodium Bicarbonate in Buffering Commonly Administered Vancomycin Hydrochloride Solutions for Use with Midline or Peripheral Line Catheters
Author(s): Puertos Enrique, Spencer Melissa
Sep/Oct 2020
Pg. 420-425
Biotin Regulates Colonization and Growth of Candida albicans in the Catheter Lumen During Nutrient Infusions
Author(s): Ohara Hiroshi, Matsuzaki Tetsuya, Ochiai Tatsuya, Hayasaka Masataka
Jan/Feb 2012
Pg. 76
Sodium Bicarbonate 4.2%, 5.0%, 7.5%, and 8.4% Injections
Author(s): Allen Loyd V Jr
Mar/Apr 2003
Pg. 142
Sodium Bicarbonate 8.4% Injection USP
Author(s): Allen Loyd V Jr
Mar/Apr 1997
Pg. 123-124
Stability of Vancomycin HCl in MEDICATION CASSETTE Reservoirs
Author(s): Allen Loyd V Jr, Stiles M Lou
Nov/Dec 2018
Pg. 516-526
Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF pH4
Author(s): Polonini Hudson, da Silva Sharlene Loures, Brandão Marcos Antônio Fernandes, Bauters Tiene, De Moerloose Barbara, Ferreira Anderson de Oliveira
Sep/Oct 2010
Pg. 421
Three Fortified Ophthalmic Solutions: Amikacin 5% Ophthalmic Solution; Ceftazidime 5% Ophthalmic Solution; Vancomycin 5% Ophthalmic Solution
Author(s): Allen Loyd V Jr
Jan/Feb 2011
Pg. 73
Vancomycin Hydrochloride 25-mg/mL Solution
Author(s): Allen Loyd V Jr
Jul/Aug 2016
Pg. 347-350
Long-term Stability of Vancomycin Hydrochloride in Oral Solution: The Brand Name Versus a Generic Product
Author(s): Huvelle Sophie, Godet Marie, Hecq Jean-Daniel, Gillet Patricia, Jamart Jacques, Galanti Laurence M
Sep/Oct 1998
Pg. 342-346
Catheter Occlusion: Causes and Solutions
Author(s): McKinnon Barbara, Lima Hetty A
Nov/Dec 2007
Pg. 511
Lidocaine Hydrochloride 1.82% Buffered Injection
Author(s): Allen Loyd V Jr
Mar/Apr 2008
Pg. 170-173
Compatibility and Stability of Palonosetron Hydrochloride with Gentamicin, Metronidazole, or Vancomycin During Simulated Y-Site Administration
Author(s): Kupiec Thomas C, Ben Michel, Trusley Craig, Trissel Lawrence A
Nov/Dec 2011
Pg. 508
Vancomycin 31-mg/mL Ophthalmic Solution
Author(s): Allen Loyd V Jr
Jan/Feb 2004
Pg. 46-48
Basics of Compounding for Disorders of the External Ear
Author(s): Allen Loyd V Jr
Nov/Dec 2017
Pg. 481-486
Basics of Compounding: Compounding Irrigation Solutions for Sterile and Nonsterile Preparations
Author(s): Allen Loyd V Jr
Sep/Oct 2015
Pg. 367-373
Compounding Pharmacies' Potential to Create Graft Storage Solutions for Bypass Surgeries
Author(s): Guth Michael AS
Jan/Feb 2016
Pg. 56
Vancomycin 5% and Amikacin 2% Ophthalmic Solution
Author(s): Allen Loyd V Jr
May/Jun 2020
Pg. 234-237
Comparative Stability Study of Unit-dose Vancomycin Hydrochloride Oral Solutions in Plastic Capped Oral Syringes and Plastic Sealed Dosage Cups
Author(s): Brown Stacy, Lewis Paul
Jan/Feb 2025
Pg. 51
Three Fortified Ophthalmic Solutions: Amikacin 5% Ophthalmic Solution; Ceftazidime 5% Ophthalmic Solution; Vancomycin 5% Ophthalmic Solution
Author(s):
Jan/Feb 2002
Pg. 55-57
New Perspectives on Vancomycin Use in Home Care, Part 2: Delivery Systems
Author(s): Kastango Eric S, Hadaway Lynn